The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Druker, B. J., Guilhot, F., O'Brien, S. G., Gathmann, I., Kantarjian, H., Gattermann, N., Deininger, M. W. N., Silver, R. T., Goldman, J. M., Stone, R. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa062867 · Cited by 3,488
Self-citationLombardo, L. J., Lee, F. Y., Chen, P., Norris, D., Barrish, J. C., Behnia, K., Castaneda, S., Cornelius, L. A. M., Das, J., Doweyko, A. M., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049486a · Cited by 1,297
Quantitative chemical proteomics reveals mechanisms of action of clinical ABL kinase inhibitors
Bantscheff, M., Eberhard, D., Abraham, Y., Bastuck, S., Boesche, M., Hobson, S., Mathieson, T., Perrin, J., Raida, M., Rau, C., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1328 · Cited by 1,034
Characteristics of human large granular lymphocytes and relationship to natural killer and K cells
Timonen, T., JR, O., & Herberman, R. (1981) · The Journal of Experimental Medicine · doi:10.1084/jem.153.3.569 · Cited by 987
Rix, U., Hantschel, O., Dürnberger, G., Remsing Rix, L. L., Planyavsky, M., Fernbach, N. V., Kaupe, I., Bennett, K. L., Valent, P., Colinge, J., et al. (2007) · Blood · doi:10.1182/blood-2007-07-102061 · Cited by 671
Hochhaus, A., Kantarjian, H. M., Baccarani, M., Lipton, J. H., Apperley, J. F., Druker, B. J., Facon, T., Goldberg, S. L., Cervantes, F., Niederwieser, D., et al. (2007) · Blood · doi:10.1182/blood-2006-09-047266 · Cited by 609
Self-citationHehlmann, R., Hochhaus, A., & Baccarani, M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61165-9 · Cited by 501
Cortes, J., Rousselot, P., Kim, D.-W., Ritchie, E., Hamerschlak, N., Coutre, S., Hochhaus, A., Guilhot, F., Saglio, G., Apperley, J., et al. (2007) · Blood · doi:10.1182/blood-2006-09-046888 · Cited by 416
Self-citationQuintás-Cardama, A., Kantarjian, H., O'Brien, S., Borthakur, G., Bruzzi, J., Munden, R., & Cortes, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0329 · Cited by 388
Kantarjian, H., Pasquini, R., Hamerschlak, N., Rousselot, P., Holowiecki, J., Jootar, S., Robak, T., Khoroshko, N., Masszi, T., Skotnicki, A., et al. (2007) · Blood · doi:10.1182/blood-2006-11-056028 · Cited by 377
Self-citationOttmann, O., Dombret, H., Martinelli, G., Simonsson, B., Guilhot, F., Larson, R. A., Rege-Cambrin, G., Radich, J., Hochhaus, A., Apanovitch, A. M., et al. (2007) · Blood · doi:10.1182/blood-2007-02-073528 · Cited by 366
Self-citationAltered Bone and Mineral Metabolism in Patients Receiving Imatinib Mesylate
Berman, E., Nicolaides, M., Maki, R. G., Fleisher, M., Chanel, S., Scheu, K., Wilson, B.-A., Heller, G., & Sauter, N. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa051140 · Cited by 319
Schade, A. E., Schieven, G. L., Townsend, R., Jankowska, A. M., Susulic, V., Zhang, R., Szpurka, H., & Maciejewski, J. P. (2008) · Blood · doi:10.1182/blood-2007-04-084814 · Cited by 296
The Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
Hantschel, O., Rix, U., Schmidt, U., Bürckstümmer, T., Kneidinger, M., Schütze, G., Colinge, J., Bennett, K. L., Ellmeier, W., Valent, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702654104 · Cited by 284
Lung Abnormalities after Dasatinib Treatment for Chronic Myeloid Leukemia: A Case Series
Bergeron, A., Réa, D., Levy, V., Picard, C., Meignin, V., Tamburini, J., Bruzzoni-Giovanelli, H., Calvo, F., Tazi, A., & Rousselot, P. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200705-715cr · Cited by 184
de Lavallade, H., Punnialingam, S., Milojković, D., Bua, M., Khorashad, J. S., Gabriel, I. H., Chaidos, A., Olavarría, E., Goldman, J. M., Apperley, J. F., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07108.x · Cited by 141
Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib
Weichsel, R., Dix, C., Wooldridge, L., Clement, M., Fenton-May, A. E., Sewell, A. K., Zezula, J., Greiner, E., Emma Gostick, D., Price, D. A., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4393 · Cited by 137
Blake, S. J., Hughes, T. P., Mayrhofer, G., & Lyons, A. B. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.02.006 · Cited by 116
Dasatinib suppresses in vitro natural killer cell cytotoxicity
Blake, S. J., Lyons, A. B., Fraser, C. K., Hayball, J. D., & Hughes, T. P. (2008) · Blood · doi:10.1182/blood-2008-02-138701 · Cited by 72
Panniculitis during Dasatinib Therapy for Imatinib-Resistant Chronic Myelogenous Leukemia
Assouline, S. E., Laneuville, P., & Gambacorti-Passerini, C. B. (2006) · New England Journal of Medicine · doi:10.1056/nejmc053425 · Cited by 67
Cited by
Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia
Koskela, H. L. M., Eldfors, S., Ellonen, P., van Adrichem, A. J., Kuusanmäki, H., Andersson, E. I., Lagström, S., Clemente, M. J., Olson, T., Jalkanen, S. E., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1114885 · Cited by 777
Self-citationSteegmann, J. L., Baccarani, M., Breccia, M., Casado, L. F., García-Gutiérrez, V, Hochhaus, A., Kim, D.-W., Kim, T. D., Khoury, H. J., Le Coutre, P., et al. (2016) · Leukemia · doi:10.1038/leu.2016.104 · Cited by 482
Self-citationImagawa, J., Tanaka, H., Okada, M., Nakamae, H., Hino, M., Murai, K., Ishida, Y., Kumagai, T., Sato, S., Ohashi, K., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00196-9 · Cited by 306
Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia
Rajala, H. L. M., Eldfors, S., Kuusanmäki, H., van Adrichem, A. J., Olson, T., Lagström, S., Andersson, E. I., Jerez, A., Clemente, M. J., Yan, Y., et al. (2013) · Blood · doi:10.1182/blood-2012-12-474577 · Cited by 294
Self-citationModulation of Immune Tolerance via Siglec-Sialic Acid Interactions
Lübbers, J., Rodríguez, E., & van Kooyk, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02807 · Cited by 260
Metadata
- Authors
- Mustjoki, S., Ekblom, M., Arstila, T. P., Dybedal, I., Epling-Burnette, P. K., Guilhot, F., Hjorth-Hansen, H., Höglund, M., Kovanen, P., Laurinolli, T., Liesveld, J., Paquette, R., Pinilla-Ibarz, J., Rauhala, A., Shah, N., Simonsson, B., Sinisalo, M., Steegmann, J. L., Stenke, L., & Porkka, K.
- Venue
- Leukemia
- Published
- 2009-03-19
- Volume
- 23
- Issue
- 8
- Pages
- 1398-1405
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2073035156
- Cited by
- 327
- References
- 20
- FWCI
- 18.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.